Know What's Happening in Healthcare

Today's Healthcare Pulse

FDA greenlights durvalumab combo for high‑risk bladder cancer

The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.

How UK Can Adopt Digital-First Community Care to Provide Equitable Healthcare
BlogMar 12, 2026

How UK Can Adopt Digital-First Community Care to Provide Equitable Healthcare

The UK National Health Service faces widening health inequities driven by ageing demographics, workforce shortages, and funding gaps, especially in deprived regions. A digital‑first community care model—leveraging remote patient monitoring, telehealth, AI‑driven personalization, and integrated data analytics—offers a pathway to...

By Journal of mHealth
INSOMNIA, TRAUMA, AND SUBSTANCES MENTAL HEALTH AND U.S. SERVICEMEMBERS
BlogMar 12, 2026

INSOMNIA, TRAUMA, AND SUBSTANCES MENTAL HEALTH AND U.S. SERVICEMEMBERS

U.S. servicemembers are experiencing a sharp increase in mental‑health diagnoses, with a 17% rise between 2022 and 2023. Only 13% of clinicians possess sufficient cultural competence to treat veteran populations, and merely 31.7% of affected personnel receive any care, while...

By War Room Podcast
Cigna Hong Kong Expands HYROX Fitness Partnership Initiatives
NewsMar 12, 2026

Cigna Hong Kong Expands HYROX Fitness Partnership Initiatives

Cigna Healthcare Hong Kong has launched the VitalGuard Critical Illness Plan, adding a lump‑sum protection product to its medical insurance suite. The plan offers up to HK$4 million coverage for 110 diseases, including 58 critical illnesses, with a 5‑year renewable term...

By Vietnam Investment Review (VIR)
Wiley and OpenEvidence Partner to Integrate Peer-Reviewed Medical Research Into Clinical AI
NewsMar 12, 2026

Wiley and OpenEvidence Partner to Integrate Peer-Reviewed Medical Research Into Clinical AI

Wiley is licensing its extensive portfolio of peer‑reviewed medical content to OpenEvidence, the clinical AI platform used by more than 40% of U.S. physicians. The deal brings the Cochrane Database of Systematic Reviews, Cochrane Clinical Answers, and over 400 Wiley...

By HIT Consultant
Breast Cancer and Menopause: Why It Happens and What Can Help
NewsMar 12, 2026

Breast Cancer and Menopause: Why It Happens and What Can Help

Breast cancer treatments, especially chemotherapy and endocrine therapy, often induce menopause or exacerbate menopausal symptoms such as hot flashes, vaginal dryness, and bone loss. These symptoms can be temporary or permanent, depending on age, treatment type, and ovarian reserve. Nonhormonal...

By Cleveland Clinic Health Essentials
How Breast Cancer Can Affect Your Heart — During Treatment and Beyond
NewsMar 12, 2026

How Breast Cancer Can Affect Your Heart — During Treatment and Beyond

Breast cancer survivors face heightened cardiovascular risk, as radiation, certain chemotherapies, HER2‑targeted drugs, and hormone treatments can impair heart function. Advances in imaging and cardiac‑sparing radiation techniques allow clinicians to detect and mitigate damage early. Oncologists now coordinate with cardiologists...

By Cleveland Clinic Health Essentials
A Third of Americans Have Cut Spending or Borrowed Money for Health Care
NewsMar 12, 2026

A Third of Americans Have Cut Spending or Borrowed Money for Health Care

A new West Health‑Gallup poll reveals that one‑third of Americans – about 82 million people – are cutting everyday expenses or borrowing money to afford health‑care. Health‑care costs now rank above food, gas and utilities as the nation’s top economic worry....

By New York Times – Science
Stryker Breach Puts IT Leaders On Alert. Here’s How To Stay Safe
NewsMar 12, 2026

Stryker Breach Puts IT Leaders On Alert. Here’s How To Stay Safe

Medical‑technology giant Stryker disclosed an Iran‑linked cyberattack that compromised its Microsoft Intune mobile device management (MDM) platform, forcing remote wipes of thousands of laptops and smartphones worldwide. The breach, claimed by the Handala collective, showed no ransomware but highlighted the...

By Forbes – Healthcare
Global Map Reveals Rapid Growth of Medical Drone Projects
SocialMar 12, 2026

Global Map Reveals Rapid Growth of Medical Drone Projects

The Global Map of Medical Drone Projects And Trials We analyzed the state of medical drones worldwide. To achieve that, we had to dive into the global literature and announcements to find all of these exciting projects that involved the use...

By Bertalan Meskó, PhD
Support Kidney Health for Underprivileged Patients Today
SocialMar 12, 2026

Support Kidney Health for Underprivileged Patients Today

Find out more about kidney health and how to support underprivileged kidney patients at https://www.kdf.org.sg (link in bio) #worldkidneyday #worldkidneyday2026

By mr brown (Lee Kin Mun)
FDA Signals Potential Updates to SUPAC Guidances—Comments Due June 1, 2026
BlogMar 12, 2026

FDA Signals Potential Updates to SUPAC Guidances—Comments Due June 1, 2026

The FDA has opened a public docket to solicit comments on its long‑standing Scale‑Up and Post‑Approval Changes (SUPAC) guidances for immediate‑release solid oral, non‑sterile semisolid, modified‑release solid oral dosage forms and the manufacturing equipment addendum. The agency seeks feedback on...

By FDA Law Blog
Australia May Ban Infant Formula Advertising. Here’s What the Online Ads Actually Say
NewsMar 12, 2026

Australia May Ban Infant Formula Advertising. Here’s What the Online Ads Actually Say

The Australian government is considering legislation to ban infant‑formula advertising as the voluntary marketing agreement expires in February 2025. Recent analysis identified 158 online ads that use health‑boosting claims to tap parental anxiety, despite breastfeeding rates falling to only 37 percent by...

By The Conversation – Business + Economy (US)
Association Between Triglyceride-Glucose Index-A Body Shape Index and Atherosclerotic Cardiovascular Disease, and the Modification Effect of Dietary Patterns
NewsMar 12, 2026

Association Between Triglyceride-Glucose Index-A Body Shape Index and Atherosclerotic Cardiovascular Disease, and the Modification Effect of Dietary Patterns

A retrospective cross‑sectional study of 13,638 Chinese adults found that the combined triglyceride‑glucose and body shape index (TyG‑ABSI) is linearly associated with atherosclerotic cardiovascular disease (ASCVD). Each unit increase in TyG‑ABSI raised the odds of ASCVD by 152 % (OR 2.52). TyG‑ABSI...

By Frontiers in Nutrition
Prognostic Value of the AIP Index in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
NewsMar 12, 2026

Prognostic Value of the AIP Index in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Researchers evaluated the atherogenic index of plasma (AIP) as a prognostic marker in 314 patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Over a median 29‑month follow‑up, each 1‑unit increase in pre‑operative AIP was linked to a...

By Frontiers in Nutrition
Association and Predictive Value of Sarcopenic Obesity for the Prognosis of Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
NewsMar 12, 2026

Association and Predictive Value of Sarcopenic Obesity for the Prognosis of Lung Cancer Patients Receiving Immune Checkpoint Inhibitors

A retrospective cohort of 119 lung‑cancer patients treated with immune checkpoint inhibitors identified sarcopenic obesity (SO) in 15% of cases. Patients with SO experienced the shortest median overall survival (22.6 months) and a three‑year hazard ratio of 3.48 for mortality,...

By Frontiers in Nutrition
Preoperative Carbohydrate Loading: Evolution, Trends, and Future Directions
NewsMar 12, 2026

Preoperative Carbohydrate Loading: Evolution, Trends, and Future Directions

A new bibliometric study maps the evolution of preoperative carbohydrate loading (PCL) research, analyzing 269 publications from 38 countries up to March 2025. China produced the most papers, while England occupied the most central position in international collaboration networks. The...

By Frontiers in Nutrition
3-Month Oral Nutritional Supplementation Adherence Impacts Positively on Survival in Malnourished Older Patients Following Hip Fracture: A Real-Life Study
NewsMar 12, 2026

3-Month Oral Nutritional Supplementation Adherence Impacts Positively on Survival in Malnourished Older Patients Following Hip Fracture: A Real-Life Study

A prospective cohort of 300 patients aged 65+ with fragility hip fractures examined how adherence to oral nutritional supplements (ONS) affected mortality. Patients who consistently retrieved ONS for at least three months showed a markedly lower 12‑month death rate (15.2%)...

By Frontiers in Nutrition
Thick Achilles Tendon Doubles Post‑Stent Cardiac Risk
SocialMar 12, 2026

Thick Achilles Tendon Doubles Post‑Stent Cardiac Risk

Your ankle is a window into your heart. A new study found that patients with a thickened Achilles tendon were nearly twice as likely to experience a major cardiovascular event within three years of a coronary stent procedure. An observational study...

By Bryan Johnson
Welcome to Wairoa – This New Training Hub Aims to Attract Frontline Health Staff
NewsMar 12, 2026

Welcome to Wairoa – This New Training Hub Aims to Attract Frontline Health Staff

New Zealand’s government has launched the second of four rural health training hubs in Wairoa, aiming to attract and retain frontline health staff. The hub will coordinate clinical placements, training pathways, and provide pastoral support such as housing and employment...

By NZ Herald – Business
HRadiO: Pets, Practice, and Professionalism - Leadership Insights From the Vet's World
NewsMar 12, 2026

HRadiO: Pets, Practice, and Professionalism - Leadership Insights From the Vet's World

HRadiO’s latest episode spotlights Dr Patrick Maguire, co‑founder of Beecroft Animal Specialist & Emergency Hospital, as he shares leadership lessons from veterinary medicine. He argues that upcoming Veterinary Practice Bill regulations will elevate professionalism, accountability, and public trust rather than add...

By Human Resources Online (Asia)
AI Co‑pilot: Adopt or Risk Obsolescence for Radiologists
SocialMar 12, 2026

AI Co‑pilot: Adopt or Risk Obsolescence for Radiologists

AI is rapidly improving at reading medical images. But the real question is not whether it will replace radiologists. Most experts see AI becoming a powerful co-pilot: spotting patterns faster, flagging anomalies earlier and helping radiologists focus on complex diagnoses and...

By Spiros Margaris
Generative AI Accelerates Smarter Analytics at HIMSS
SocialMar 12, 2026

Generative AI Accelerates Smarter Analytics at HIMSS

Interaction #Analytics Topic #AI Delivers Faster, Smarter Analysis with #GenerativeAI. Visit Booth 4843 to see #AI-first #CX in action. @NICELtd #HIMSS26 #HIMSS2026 https://t.co/2Ji4nhmAmx

By James Gingerich
Vantive Executive Discusses Reframing Vietnam's Dialysis Challenge
NewsMar 12, 2026

Vantive Executive Discusses Reframing Vietnam's Dialysis Challenge

Vantive executive Paul Uthaichalanond highlighted Vietnam's dialysis bottleneck, noting only 5‑10% of roughly 800,000 ESRD patients receive therapy and that 80% of treatments rely on overcrowded hemodialysis centers. He contrasted this with Thailand’s successful “PD‑first” approach, which reduced costs and...

By VNExpress – Companies (subset)
NiCE Sets Real‑Time AI‑First Care Standard
SocialMar 12, 2026

NiCE Sets Real‑Time AI‑First Care Standard

NiCE is defining the next standard of care... with data that moves as fast as the patient. Visit Booth 4843 to see #AI-first #CX in action. @NICELtd #HIMSS26 #HIMSS2026 https://t.co/3ffKU5tupi

By James Gingerich
Probiotic L. Paracasei DG I1572 Combats Vascular Inflammaging
SocialMar 12, 2026

Probiotic L. Paracasei DG I1572 Combats Vascular Inflammaging

Gut Microbiota Manipulation by Probiotic Lacticaseibacillus paracasei DG I1572 as New Therapeutical Strategy to Counteract Vascular Inflammaging https://t.co/91dumlTNgU https://t.co/tkL0m8P6nd

By David Barzilai, MD PhD
Dementia Telehealth Company Isaac Health Adding Health Systems to Partner Mix
NewsMar 12, 2026

Dementia Telehealth Company Isaac Health Adding Health Systems to Partner Mix

Isaac Health, a telehealth platform for brain health and dementia, announced a partnership with NYU Langone Health, adding a major health‑system channel to its primarily payer‑focused model. The collaboration creates an integrated referral pathway that combines virtual specialty care with...

By Healthcare Innovation
U.S. Cancer Deaths Down 35% Since 1990
SocialMar 12, 2026

U.S. Cancer Deaths Down 35% Since 1990

Cancer deaths in the U.S. peaked around 1990. After adjusting for aging of the population, mortality has fallen by about 35% since then. The biggest drivers: • Smoking declined dramatically • Screening improved • Treatments got better A massive and often overlooked public health success. https://t.co/Ev7pSnunoY

By Siim Land
HHS and White House Missed Autism, Need Innovative Turnaround
SocialMar 12, 2026

HHS and White House Missed Autism, Need Innovative Turnaround

Here’s my take on what HHS and the White House got wrong about autism in 2025-2026 and how they could turn this around and do something innovative and helpful https://t.co/pxLaDLInlf

By Peter Hotez
What Hospital Systems Want From Home Health Providers
NewsMar 12, 2026

What Hospital Systems Want From Home Health Providers

Ascension, a 97,000‑employee health system, is demanding faster, more reliable home‑health services from partner agencies. The system requires same‑day or next‑day visits, referral acceptance within minutes, and acceptance rates above 85%, far higher than the industry average. To improve coordination,...

By Home Health Care News
Cearvol Nano OTC Hearing Aids Boost Volume Everywhere
SocialMar 12, 2026

Cearvol Nano OTC Hearing Aids Boost Volume Everywhere

Wish you could hear everything around you, whether you're at a noisy restaurant or just watching TV at home? I check out the Cearvol Nano OTC Hearing Aids in various locations and find it's a great way to turn up...

By Dave Taylor
New Tissue Models Accelerate Liver Disease Drug Development
SocialMar 12, 2026

New Tissue Models Accelerate Liver Disease Drug Development

New tissue models could help researchers develop drugs for liver disease by Anne Trafton @MIT Learn more: https://t.co/hkeRZ0W47B #HealthTech #EmergingTech #TechForGood #Innovation https://t.co/LNvft8iX9M

By Ron van Loon
Capricor Therapeutics Inc (CAPR) Q4 2025 Earnings Call Transcript
NewsMar 12, 2026

Capricor Therapeutics Inc (CAPR) Q4 2025 Earnings Call Transcript

Capricor Therapeutics reported fourth‑quarter 2025 revenue of $16 million, a modest 4% year‑over‑year increase, while gross margin rose to 86% driven by higher selling prices and manufacturing efficiencies. Net loss widened to $11.9 million as operating expenses outpaced revenue growth, but the...

By Motley Fool – Earnings Transcripts
Another Pandemic Likely; Corrupt Orgs Profit, Humanity Suffers
SocialMar 12, 2026

Another Pandemic Likely; Corrupt Orgs Profit, Humanity Suffers

Well yes, another pandemic is likely, we’ve had a dozen in this new century for reasons I’ve detailed in my 2021 book, Preventing the Next Pandemic @JHUPress it’s demoralizing to watch corrupt organizations exploit this for their financial gain, imagine...

By Peter Hotez
Oncology Institute Inc (TOI) Q4 2025 Earnings Call Transcript
NewsMar 12, 2026

Oncology Institute Inc (TOI) Q4 2025 Earnings Call Transcript

The Oncology Institute reported Q2 2025 revenue of $119.8 million, a 21.5% year‑over‑year increase, driven by a 41% surge in pharmacy sales that now represent 52% of total revenue. Gross profit rose 34% YoY while SG&A fell to 22% of revenue,...

By Motley Fool – Earnings Transcripts
Champions Oncology Inc (CSBR) Q3 2026 Earnings Call Transcript
NewsMar 12, 2026

Champions Oncology Inc (CSBR) Q3 2026 Earnings Call Transcript

Champions Oncology reported $14 million revenue in Q1 FY2026, flat year‑over‑year and rebounding from a $12.4 million Q4 dip. GAAP operating loss widened to $0.5 million, while adjusted EBITDA turned slightly positive at $60 000. Gross margin slipped to 43% as outsourced radio‑labeling costs...

By Motley Fool – Earnings Transcripts
Vaxart Inc (VXRT) Q4 2025 Earnings Call Transcript
NewsMar 12, 2026

Vaxart Inc (VXRT) Q4 2025 Earnings Call Transcript

Vertex Pharmaceuticals reported Q4 2025 revenue of $3.2 billion, a 10% quarterly increase, and $12 billion for the full year, up 9% year‑over‑year. Gross margin reached 85.7% and non‑GAAP net income rose 24% to $1.3 billion, underscoring strong profitability. New product...

By Motley Fool – Earnings Transcripts
Nektar Therapeutics (NKTR) Q4 2025 Earnings Call Transcript
NewsMar 12, 2026

Nektar Therapeutics (NKTR) Q4 2025 Earnings Call Transcript

Nektar Therapeutics reported strong Q4 2020 results, highlighting robust progress on its cytokine platform. The IL‑2 agonist BEMPEG demonstrated a median progression‑free survival of 30.9 months in melanoma and is now enrolled in six registrational trials across melanoma, renal, bladder,...

By Motley Fool – Earnings Transcripts
V.A. Begins Drive to Put Some Homeless Veterans Into Guardianship
NewsMar 11, 2026

V.A. Begins Drive to Put Some Homeless Veterans Into Guardianship

The Trump administration announced that the Department of Justice will grant the Veterans Affairs (VA) department authority to initiate guardianship proceedings for veterans deemed unable to make health‑care decisions. The policy targets homeless veterans and those without family, allowing state...

By New York Times – Health
DNA Origami Vaccine Rivals mRNA Shots While Being Easier to Store and Manufacture
NewsMar 11, 2026

DNA Origami Vaccine Rivals mRNA Shots While Being Easier to Store and Manufacture

Researchers at Harvard’s Wyss Institute and Dana‑Farber unveiled DoriVac, a DNA origami‑based vaccine platform that delivers antigens and adjuvants on a self‑folding nanostructure. In pre‑clinical mouse studies and a human lymph‑node‑on‑a‑chip model, DoriVac generated antibody and T‑cell responses comparable to...

By Phys.org – Nanotechnology
Environmentally Sustainable Prescribing of Diabetes Medication
NewsMar 11, 2026

Environmentally Sustainable Prescribing of Diabetes Medication

The BMJ rapid response argues that environmentally sustainable prescribing of diabetes medication must extend beyond the waste generated by GLP‑1 agonist pens. It details how the chemically intensive production of peptide drugs and the disposable nature of insulin pens, pumps...

By BMJ (Latest)
Startup Vima Adds Parkinson’s to Movement Disorder Scope, Expanding Series A Round to $100M
NewsMar 11, 2026

Startup Vima Adds Parkinson’s to Movement Disorder Scope, Expanding Series A Round to $100M

Vima Therapeutics announced an additional $40 million raise, taking its Series A funding to $100 million. The capital will support parallel Phase 2 trials of its lead candidate VIM0423 in isolated dystonia and Parkinson’s disease, expanding the startup’s focus beyond the rare movement disorder....

By MedCity News
200,000+
SocialMar 11, 2026

200,000+

Yes @JReinerMD and they left out how how >200,000 Americans died needlessly bc they refused Covid vaccinations in 2021-23. Victims of an organized antivaccine disinformation campaign, now being repeated in this new version of HHS

By Peter Hotez
Carrum, Virta Join Forces on Employer Weight Management Solution
NewsMar 11, 2026

Carrum, Virta Join Forces on Employer Weight Management Solution

Carrum Health and Virta Health announced a partnership delivering a full‑spectrum weight‑management solution for self‑insured employers. The collaboration links Carrum’s value‑based surgical care with Virta’s virtual nutrition coaching, medication management and GLP‑1 prescribing. It creates a seamless pathway from conservative...

By MedCity News
NY Blood Center Opens First Bronx Location in Throggs Neck
NewsMar 11, 2026

NY Blood Center Opens First Bronx Location in Throggs Neck

The New York Blood Center opened a 4,000‑square‑foot donor center in the Throggs Neck Shopping Center, marking its first facility in the Bronx and the 21st in the Tri‑State area. The ribbon‑cutting ceremony featured Bronx Borough President Vanessa Gibson and local officials....

By Connect CRE
‘Phone-a-Friend’: On-Call Coaching Model Helps Nursing Homes Improve Care Quality
NewsMar 11, 2026

‘Phone-a-Friend’: On-Call Coaching Model Helps Nursing Homes Improve Care Quality

The Moving Forward Nursing Home Quality Coalition piloted an on‑call coaching model paired with Quality Assurance and Performance Improvement (QAPI) and leadership training in four low‑rated, high‑Medicaid facilities in Michigan. At Fountain Bleu, hospitalizations dropped from 60% to 22% and...

By Skilled Nursing News
Skilled Nursing Dealbook: NY Nursing Home Sells for $75M; Selectis Selling 2 Facilities to Journey for $15.7M
NewsMar 11, 2026

Skilled Nursing Dealbook: NY Nursing Home Sells for $75M; Selectis Selling 2 Facilities to Journey for $15.7M

The skilled‑nursing market saw several high‑profile transactions this week. Excelsior Group acquired the 280‑bed Union Plaza Care Center in Flushing, New York for $75 million, while Selectis Health agreed to sell its two Georgia facilities—Glen Eagle and Eastman Healthcare—totaling 201 beds...

By Skilled Nursing News
Can FDA Tolerate Cancer Risk for Rare Pediatric Disease Gene Therapies?
NewsMar 11, 2026

Can FDA Tolerate Cancer Risk for Rare Pediatric Disease Gene Therapies?

The FDA placed a clinical hold on Regenxbio’s RGX‑111 and RGX‑121 gene‑therapy trials after a pediatric MPS I patient developed a tumor four years post‑treatment. The case marks the first documented long‑latency cancer linked to an adeno‑associated virus (AAV) vector in...

By BioCentury
Phase 2 Trial Compares Dara‑Bor
SocialMar 11, 2026

Phase 2 Trial Compares Dara‑Bor

EAA241 - Ph 2 RCT Dara-Bor-Dex vs Cy-Bor-Dex in the treatment of Newly Diagnosed Multiple Myeloma with Light Chain Cast Nephropathy (LCCN) [Study activated 8/11/25] @keruakous https://t.co/1NgvVZ3fTA #NCT07085728 #mmsm @eaonc https://t.co/IvK3UNeem9

By Mike Thompson, MD PhD
Daratumumab Boosts Revlimid Efficacy in Smoldering Myeloma
SocialMar 11, 2026

Daratumumab Boosts Revlimid Efficacy in Smoldering Myeloma

#EAonc EAA173 - Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM) - PI: @nsc_natalie https://t.co/VtBMJUjI5X Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd https://t.co/ikQKjHjscU

By Mike Thompson, MD PhD